Outcome of Board Meeting held on July 24, 2026 - Approval for fund raising
As filed · Neogen Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on July 24, 2026 - Approval for fund raising.
What happened
FactNEOGEN announced the outcome of its Board Meeting held on July 24, 2026, where it approved the un-audited financial results for the quarter ended June 30, 2026, along with the Limited Review Report from its statutory auditors. The company will convene its 37th Annual General Meeting on August 21, 2026, via video conferencing, with a record date of August 13, 2026, for determining eligibility for remote e-voting and final dividend. The register of members will be closed from…
Why it matters
CapitSignal interpretationRaising capital changes the share count or the debt load, and the stated use of proceeds is a commitment that can later be checked.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
ContradictedPakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027
Dahej Phase 1 project cost stands at INR 428 crore with target completion by February 2027, while Pakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Instrument and amount finally raised
- Stated use of proceeds
- Whether the enabling resolution is actually used
- 1,000 MT to be commissioned by H2 FY27 (management committed by H2 FY27)
- Looking ahead, as the replacement Dahej plant begins regular commercial operations and Neogen Ionics (NIL) cap (management committed by H2 FY27)
Evidence
- Outcome of Board Meeting(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q4 FY26
How CapitSignal classified this
- Reasoning:
- FUNDRAISE base 58; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%